In November 2010, members of the Association of the British Pharmaceutical Industry (ABPI) voted in favour of changes to its Code of Practice, with a view to breaking down ‘barriers to trust’ between healthcare professionals and the pharma. The amendments apply to clauses regarding consultant payments and meeting sponsorship.
Under the new 2011 Code, pharma companies [...]
PharmExec Blog
Follow Us
RSS
Bookstore
New Transparency in UK Pharma: A Bitter Pill to Swallow?